a Canadian biopharmaceutical company developing novel immune-oncology vaccines and drug delivery technologies, is pleased to announce a project consisting of investigating the potential benefit of using the Accum® technology to increase the half...
利拉鲁肽是一款新型胰高血糖素样肽-1受体激动剂（ GLP⁃１ＲＡ），目前主要通过基因重组改造的酒酿...
In comes Pfizer’s danuglipron, an oral GLP-1 receptor agonist. As one of the world’s largest pharmaceutical companies, Pfizer’s entry into the obesity market with an oral med could change the game for weight loss treatments. Let’s get into what danuglipron is, how it works and what...
^Thomas MK, Nikooienejad A, Bray R, Cui X, Wilson J, Duffin K, Milicevic Z, Haupt A, Robins DA. Dual GIP and GLP-1 Receptor Agonist Tirzepatide Improves Beta-cell Function and Insulin Sensitivity in Type 2 Diabetes. J Clin Endocrinol Metab. 2021 Jan 23;106(2):388-396. doi ^Del...
Liraglutide is a glucagon-like peptide-1 (GLP-1) receptor agonist 97% similar to native GLP-17 which is secreted by intestinal L-cells at the level of the distal jejunum, ileum and colon in response to the ingestion of carbohydrates, lipids and mixed food. It reduces blood sugar levels, ...
International Journal of Environmental Research and Public Health Article Resistance Exercise Training Attenuates the Loss of Endogenous GLP-1 Receptor in the Hypothalamus of Type 2 Diabetic Rats Se Hwan Park 1, Jin Hwan Yoon 1, Dae Yun Seo 2 , Tae Nyun Kim 2, Jeong Rim Ko 2 and Jin Han ...
International Journal of Molecular Sciences Article GLP-1 Analogue Liraglutide Attenuates Mutant Huntingtin-Induced Neurotoxicity by Restoration of Neuronal Insulin Signaling Ching-Chi Chang 1,2,†, Tzu-Chin Lin 2,†, Hsiao-Li Ho 1, Chien-Yin Kuo 1, Hsin-Hua Li 1, Tatiana A. Korolenko 3,...